000			01779 a2200505 4500
005			20250517144802.0
264		0	_c20171215
008			201712s 0 0 eng d
022			_a1872-9096
024	7		_a10.1016/j.antiviral.2017.03.014 _2doi
040			_aNLM _beng _cNLM
100	1		_aMounce, Bryan C
245	0	0	_aCurcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding. _h[electronic resource]
260			_bAntiviral research _c06 2017
300			_a148-157 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntiviral Agents _xpharmacology
650	0	4	_aCell Line
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aChikungunya Fever _xdrug therapy
650	0	4	_aChikungunya virus _xdrug effects
650	0	4	_aChlorocebus aethiops
650	0	4	_aCoxsackievirus Infections _xdrug therapy
650	0	4	_aCurcumin _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEnterovirus _xdrug effects
650	0	4	_aHeLa Cells
650	0	4	_aHumans
650	0	4	_aInhibitory Concentration 50
650	0	4	_aRNA, Viral _xdrug effects
650	0	4	_aVero Cells
650	0	4	_aVesicular stomatitis Indiana virus _xdrug effects
650	0	4	_aVirus Attachment _xdrug effects
650	0	4	_aVirus Internalization _xdrug effects
650	0	4	_aVirus Replication _xdrug effects
650	0	4	_aZika Virus _xdrug effects
650	0	4	_aZika Virus Infection _xdrug therapy
700	1		_aCesaro, Teresa
700	1		_aCarrau, Lucia
700	1		_aVallet, Thomas
700	1		_aVignuzzi, Marco
773	0		_tAntiviral research _gvol. 142 _gp. 148-157
856	4	0	_uhttps://doi.org/10.1016/j.antiviral.2017.03.014 _zAvailable from publisher's website
999			_c27016890 _d27016890